Endpoints News Add us as a preferred source on Google
🔄 Data last refreshed 1 month ago
🤝
Make a deal with Endpoints News
🔒 Paid proposals held safely in escrow — released only when the work's approved.
Followers
3.2K
Account age
1 yrs
💰 Suggested sponsorship rate
$40 – $65 / sponsored post
Estimated from audience size & typical reach — every deal is negotiable and held in SocialDB escrow.
🎁 Free analysisfor Endpoints News
📊 Post engagement
Recent posts · likes + reposts
Sep 21latest
3
Avg engagement / post
2–4
Typical post (engagement)
0.1%
Engagement vs followers
84/100
Very consistent reach
Nov 2024
On Bluesky since
Half of recent posts land between 2 and 4 likes + reposts (median 2) — a dependable floor a sponsored post can count on.
🔥 Top post: Roche said its Carmot-acquired obesity drug hit both goals of a · 4 likes + reposts
📊 Activity & format
Posting cadence
30 / week
Posts daily — consistently active for a campaign window.
Content mix
Mostly text
Recent: 11 text · 1 image · 0 video.
Follower / following
5.3×
Follows 604 back. A strong ratio — an audience that follows them, not a follow-for-follow network.
Recent posts
View on Bluesky ↗
Heidi Overton, Trump's pick to run the FDA, faces the Senate on Thursday. We're live blogging the hearing.
Kyverna's CAR-T improved mobility by a median 49% at one year in patients with stiff person syndrome, data it plans to take to the FDA by the end of this year.
Lilly signed another China deal, this one with Beijing's InnoCare for up to $3.35B across five drug targets.
Roche's kidney drug hit its Phase 3 goal, setting up a bid for accelerated approval in a crowded market.
Basecamp Research raised $140M and revealed a six-program pipeline, the first test of whether its AI models can turn DNA data into drugs.
A pregnant mom. A fetal diagnosis. Medication from a secret network. 'There was no protocol'
Roche's kidney drug passed a Phase 3 test, clearing a path to accelerated approval in a market Novartis already sells into.
Nvidia-backed Iambic filed for a Nasdaq IPO, disclosing updated data on its HER2 drug and what pharma has paid for access to its AI platform.
A new ARPA-H program is funding autonomous AI to diagnose and prescribe for heart failure at home, a test of how far clinical AI can go and who will trust it.
Thursday: Eleven private biotechs made the 2026 Endpoints 11. Join us for the gala dinner with the founders, investors and the editors who chose them. Can't make the gala? The Sept. 28 virtual experience is free. Register now. events.endpo…
Pfizer and Lilly's "most favored nation" contracts suggest the US will get a cut of revenue from the price hikes they make overseas.
🦋 Handle & authenticity
✅ Domain-verified
@endpts.com
The handle is the domain endpts.com. On Bluesky a domain handle proves the owner controls that website — so this is verifiably the real endpts.com account, not an impersonator.
On Bluesky since
Nov 2024
Joined after Bluesky opened to the public — a settled account with a real history.
💡 Facts
🗓️Joined Bluesky in 2024 — 1 year ago.
👁️Averages 3 views per post.
📤Posts about 30× per week.
🕵️ Fake follower check
Estimated61/100
Fair
Credibility score
84%
Real
Real audience
Low
Fake-follower risk
High
Data confidence
- Est. 84% real, active audience · Low fake-follower risk.
- Engagement (~0.1% of followers engage each post) is around typical for Bluesky.
Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.
About
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
🔀 Audience overlap
EstimatedEstimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.
More like this
Find more →
Bluesky
＋
ANTIFA☆licia
@hellofelicia.bsky.social
3.2K
Followers
Bluesky
＋
Deadpimp420 🏆
@deadpimp420.bsky.social
3.2K
Followers
Bluesky
＋
fontaine99.bsky.social
@fontaine99.bsky.social
3.2K
Followers
Bluesky
＋
Hosey Leopardo
@hoebigcat.bsky.social
3.2K
Followers
Bluesky
＋
Jason Song Quinn (Comms Open)
@hulkhoquinn.bsky.social
3.2K
Followers
Bluesky
＋
Terry
@terryteabag.bsky.social
3.2K
Followers
Frequently asked questions
How much does Endpoints News charge for a sponsorship?
Endpoints News hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.
How do I contact Endpoints News for a brand deal or collaboration?
Send a paid deal or collab request right here on SocialDB — we notify Endpoints News, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.
How many followers does Endpoints News have?
Endpoints News has 3,184 followers on Bluesky.
✉ Message Endpoints News
Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.
- ✓ Message any influencer from their listing
- ✓ The influencer gets notified by email
- ✓ Manage every conversation in one inbox
Already Pro? Log in.
🎤 Event / appearance with Endpoints News
Booking an event / appearance is a Pro feature. Upgrade to book Endpoints News for an in-person or virtual appearance — payment held safely in escrow until the event is done.
- ✓ Book them for events, livestreams, panels & more
- ✓ Endpoints News gets notified by email
- ✓ Fee held in escrow, released after the appearance
Already Pro? Log in.
🚀
You're out of free requests this month
Free accounts get 5 per month. Go Pro for unlimited sponsor pitches, collab requests & sponsorship deals — plus featured placement, the Verified badge, free withdrawals and more.
Upgrade to Pro — $9.95/mo →Your free limit resets on the 1st of next month.
Auto-generated from Bluesky's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove